Back to Top Skip to main content Skip to sub-navigation

COVID-19 Vaccine Efforts

On Aug. 23, 2021, the U.S. Food and Drug Administration issued formal licensure of the Pfizer-BioNTech COVID-19 vaccine, now called COMIRNATY®. This licensure is based on rigorous studies demonstrating efficacy and safety through data collected over the past year.

Due to continuing impacts of the COVID-19 pandemic on Department operations, Secretary Austin directed Secretaries of the Military Departments on Aug. 24, 2021 to immediately begin full vaccination of all members of the Armed Forces under DoD authority. This requirement includes active duty or in the Ready Reserve, including National Guard, who are not fully vaccinated against COVID-19. Services will specify implementation timelines according to each Service’s implementation plan.

The Centers for Disease Control and Prevention (CDC) state their Advisory Committee on Immunization Practices uses a formal evidence process in their reviews, and holds public meetings where the evidence is reviewed before deliberation occurs. This process complements public deliberations carried out by the FDA’s Vaccines and Related Biological Products Advisory Committee.

Following CDC guidance, DOD will continue to adjust health protection protocols to the local conditions of the communities in which we serve. The Department’s priorities include:

  • Protecting our Service members, DOD civilians, and families
  • Safeguarding our national security capabilities
  • Supporting the whole-of-nation response to the COVID-19 pandemic

Getting a COVID-19 vaccine helps protect you, your family, your community and our nation. Eligible and authorized TRICARE beneficiaries can make a COVID-19 vaccine appointment, as available, at a DOD vaccination site.

COVID-19 Vaccine Toolkit Page TRICARE Beneficiary Information

COVID-19 Vaccine Safety

COVID-19 vaccines authorized in the United States continue to be remarkably effective in reducing risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant.

The CDC confirms COVID-19 vaccines are safe and effective and recommend that all persons get COVID-19 vaccinations as soon as possible. In addition to the newly licensed Pfizer-BioNTech COVID-19 vaccine, now called COMIRNATY®, several COVID-19 vaccines have been offered through FDA’s Emergency Use Authorization.  

COVID-19 vaccine development has processes and procedures in place to help ensure the safety of any vaccine authorized for use. Vaccines for COVID-19 are only available after they are:

  • Demonstrated to be safe and effective in large phase three clinical trials
  • Authorized by the U.S. Food and Drug Administration
  • Manufactured and distributed safely and securely

Visit the CDC Website to learn more about COVID-19 vaccines.

You also may be interested in...

DHA Form 207: COVID-19 Vaccine Screening and Immunization Document, v13


The purpose of this form is to determine if the COVID-19 vaccine can be administered to the patient. (v13, August 2021)

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Information for Military Treatment Facility Directors
Showing results 1 - 1 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.